Kristen Fortney

CEO, BioAge Labs

Kristen is the co-founder and CEO of BioAge, a clinical-stage biotechnology company with a mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen received her PhD from the University of Toronto, followed by postdoctoral training at Stanford. She has 15 years of experience developing novel bioinformatics approaches to investigate aging-related diseases, with over 20 published papers in computational drug discovery, biomarkers, and the genetics of human longevity.

Social Media

• LinkedIn
• Twitter